What is CAI's five-year median P/S?

6.0x. Half of CAI's weekly readings since May 2026 were higher and half were lower. This page has 26 weekly readings, from May 4, 2026 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares CAI only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Caris Life Sciences Inc (CAI) P/S ratio history

Health Care

$35.82

Latest weekly close · Market cap $10.1B

Historically high

Caris Life Sciences' P/S of 10.2x is higher than 98% of its weekly readings since May 2026 (as of Oct 29, 2026).

Forward P/E 96.3× (analyst estimates, not ranked).

Weekly P/S since May 2026

P/S each weekMiddle half of its readingsMedian 6.0×

Median: 6.0×
Low to high: 4.5× to 10.2×
Versus median: +71%
History starts: May 2026

P/S

98thpercentile

of its weekly readings since May 2026

Growth, last 12 months vs the year before

Revenue: +85%
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

No full calendar year of readings yet.

Health Care peers on P/S

Each percentile compares a stock with its own last five years.

Compare CAI with peers

Health Care peers of CAI on P/S
Stock	P/S	Versus its own history	5-year percentile
ABBVAbbVie	7.9×	Historically high	100
AMGNAmgen	6.5×	Historically high	99
ARWRArrowhead Pharmaceuticals Inc	12.9×	Within its usual range	37
BBIOBridgebio Pharma Inc	19.4×	Below its usual range	19
BIIBBiogen	3.5×	Above its usual range	73

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on CAI

No articles about CAI yet. How valuation percentiles work

Loading peers and related research…

About this history

What is CAI's current P/S?: Caris Life Sciences' P/S of 10.2x is higher than 98% of its weekly readings since May 2026 (as of Oct 29, 2026).
What is CAI's five-year median P/S?: 6.0x. Half of CAI's weekly readings since May 2026 were higher and half were lower. This page has 26 weekly readings, from May 4, 2026 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares CAI only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.